GlassScriptPhysician profile
Lawrence G Cox
NPI 1871559393
$19,017.62
in general payments reported to CMS, 2019-2025
53 companies · $1,624 in 2025
The $1,624 reported for 2025 was more than what 93% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,769 · 2020: $2,444 · 2021: $3,397 · 2022: $3,523 · 2023: $3,033 · 2024: $2,227 · 2025: $1,624.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,884.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,884.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $3,482.78 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Abbvie INC. | $2,723.60 | 2019-2025 | Ubrelvy, Qulipta, Vraylar |
| Glaxosmithkline, LLC. | $2,091.61 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,195.05 | 2019-2025 | Jardiance, Stiolto Respimat, Spiriva Respimat |
| Lilly USA, LLC | $1,101.92 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $940.41 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $650.68 | 2019-2025 | Farxiga, Breztri, Saphnelo |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $632.38 | 2019-2025 | Xifaxan, Trulance |
| Janssen Pharmaceuticals, INC | $623.47 | 2019-2025 | Spravato |
| Amgen INC. | $599.50 | 2019-2025 | Evenity, Prolia, Repatha |
| Allergan, INC. | $536.05 | 2019-2020 | |
| Tactile Systems Technology INC | $457.28 | 2020-2024 | Entre Plus, Flexitouch Plus |
| Merck Sharp & Dohme LLC | $446.51 | 2019-2025 | Vaxelis, Gardasil 9, Vaxneuvance |
| Takeda Pharmaceuticals U.S.A., INC. | $427.60 | 2019-2025 | Trintellix |
| Abbott Laboratories | $297.78 | 2021-2025 | Freestyle Libre 3 |
Show all 53 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Cox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.